MX2020012237A - Proteccion de moleculas biologicamente activas durante esterilizacion por radiacion. - Google Patents
Proteccion de moleculas biologicamente activas durante esterilizacion por radiacion.Info
- Publication number
- MX2020012237A MX2020012237A MX2020012237A MX2020012237A MX2020012237A MX 2020012237 A MX2020012237 A MX 2020012237A MX 2020012237 A MX2020012237 A MX 2020012237A MX 2020012237 A MX2020012237 A MX 2020012237A MX 2020012237 A MX2020012237 A MX 2020012237A
- Authority
- MX
- Mexico
- Prior art keywords
- biologically active
- biological
- radiation
- active molecules
- sterilization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
- A61L2/08—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
- A61L2/08—Radiation
- A61L2/081—Gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
- A61L2/08—Radiation
- A61L2/087—Particle radiation, e.g. electron-beam, alpha or beta radiation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2103/00—Materials or objects being the target of disinfection or sterilisation
- A61L2103/05—Living organisms or biological materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862673671P | 2018-05-18 | 2018-05-18 | |
| PCT/US2019/032885 WO2019222638A1 (en) | 2018-05-18 | 2019-05-17 | Protection of biologically active molecules during radiation sterilization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020012237A true MX2020012237A (es) | 2021-03-25 |
Family
ID=66770587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020012237A MX2020012237A (es) | 2018-05-18 | 2019-05-17 | Proteccion de moleculas biologicamente activas durante esterilizacion por radiacion. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210260225A1 (enExample) |
| EP (1) | EP3793621A1 (enExample) |
| JP (2) | JP7487184B2 (enExample) |
| KR (2) | KR102774917B1 (enExample) |
| CN (1) | CN112135641A (enExample) |
| AU (2) | AU2019269671B2 (enExample) |
| MX (1) | MX2020012237A (enExample) |
| SG (1) | SG11202009795PA (enExample) |
| WO (1) | WO2019222638A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114621467B (zh) * | 2022-05-17 | 2022-07-29 | 天新福（北京）医疗器材股份有限公司 | 一种无菌自固化胶原蛋白修复凝胶及其制备方法 |
| CN115611978B (zh) * | 2022-11-21 | 2023-03-07 | 成都奇璞生物科技有限公司 | 一种辐照保护剂在制备胶原蛋白产品中的用途 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2649224B2 (ja) * | 1987-02-25 | 1997-09-03 | 旭メディカル 株式会社 | 体液処理装置の滅菌方法および滅菌された体液処理装置 |
| US6551794B1 (en) * | 1995-11-09 | 2003-04-22 | E. R. Squibb & Sons, Inc. | Stable biotinylated biomolecule composition |
| JP4071283B2 (ja) * | 1996-02-05 | 2008-04-02 | 旭化成クラレメディカル株式会社 | 滅菌保護剤及び滅菌方法 |
| US5730933A (en) * | 1996-04-16 | 1998-03-24 | Depuy Orthopaedics, Inc. | Radiation sterilization of biologically active compounds |
| EP1762251A1 (en) * | 2000-03-23 | 2007-03-14 | Clearant, Inc. | Methods for sterilizing biological materials |
| US20030012687A1 (en) | 2000-03-23 | 2003-01-16 | Macphee Martin J. | Methods of sterilizing biological materials |
| US20040086420A1 (en) | 2000-03-23 | 2004-05-06 | Macphee Martin J. | Methods for sterilizing serum or plasma |
| US6682695B2 (en) * | 2001-03-23 | 2004-01-27 | Clearant, Inc. | Methods for sterilizing biological materials by multiple rates |
| US6696060B2 (en) * | 2001-06-14 | 2004-02-24 | Clearant, Inc. | Methods for sterilizing preparations of monoclonal immunoglobulins |
| US6946098B2 (en) | 2001-08-10 | 2005-09-20 | Clearant, Inc. | Methods for sterilizing biological materials |
| US20030031584A1 (en) | 2001-08-10 | 2003-02-13 | Wilson Burgess | Methods for sterilizing biological materials using dipeptide stabilizers |
| US7252799B2 (en) * | 2001-08-31 | 2007-08-07 | Clearant, Inc. | Methods for sterilizing preparations containing albumin |
| US6749851B2 (en) * | 2001-08-31 | 2004-06-15 | Clearant, Inc. | Methods for sterilizing preparations of digestive enzymes |
| EP1415669A1 (en) * | 2002-09-19 | 2004-05-06 | Aventis Behring GmbH | Process for sterilization of protein containing biological compositions |
| US20050069453A1 (en) | 2003-09-29 | 2005-03-31 | Ren-Yo Forng | Methods for sterilizing preparations of urokinase |
| US20050175630A1 (en) * | 2003-12-23 | 2005-08-11 | Eyal Raz | Immunogenic compositions and methods of use thereof |
| GB0626021D0 (en) * | 2006-12-29 | 2007-02-07 | Insense Ltd | The stabilisation of proteins |
| US8304439B1 (en) * | 2007-10-12 | 2012-11-06 | Politechnika Lodzka | Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage |
| EP2236520A1 (en) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Stabilizing composition for immobilized biomolecules |
| EP2236617A1 (en) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Methods of terminal sterilization of biofunctional compositions |
| US8999720B2 (en) * | 2011-11-17 | 2015-04-07 | Medtronic Minimed, Inc. | Aqueous radiation protecting formulations and methods for making and using them |
| CN108064229B (zh) * | 2015-03-12 | 2021-12-28 | 三洋化成工业株式会社 | 蛋白质组合物的制造方法和蛋白质组合物 |
| WO2016146573A1 (en) * | 2015-03-13 | 2016-09-22 | Repoceuticals Aps | Melatonin for preventing and treating radiation cystitis |
| US20160354500A1 (en) * | 2015-06-02 | 2016-12-08 | Medtronic Minimed, Inc. | Protective agents against e-beam irradiation for proteins in optical sensing chemistry |
| CN109640981A (zh) * | 2016-06-29 | 2019-04-16 | 曼隆治疗公司 | 神经激肽-1拮抗剂用于治疗多种瘙痒病症的用途 |
| WO2019166003A1 (zh) * | 2018-03-02 | 2019-09-06 | 郑州大学 | 14-脱氧-11,12-脱氢-8,12-环氧或7,8-烯-穿心莲内酯及其15位取代衍生物和用途 |
-
2019
- 2019-05-17 SG SG11202009795PA patent/SG11202009795PA/en unknown
- 2019-05-17 AU AU2019269671A patent/AU2019269671B2/en active Active
- 2019-05-17 WO PCT/US2019/032885 patent/WO2019222638A1/en not_active Ceased
- 2019-05-17 CN CN201980033117.0A patent/CN112135641A/zh active Pending
- 2019-05-17 MX MX2020012237A patent/MX2020012237A/es unknown
- 2019-05-17 KR KR1020207032785A patent/KR102774917B1/ko active Active
- 2019-05-17 US US17/056,393 patent/US20210260225A1/en active Pending
- 2019-05-17 JP JP2021514951A patent/JP7487184B2/ja active Active
- 2019-05-17 KR KR1020257006233A patent/KR20250030028A/ko active Pending
- 2019-05-17 EP EP19728822.8A patent/EP3793621A1/en active Pending
-
2024
- 2024-02-26 JP JP2024026729A patent/JP2024073470A/ja active Pending
-
2025
- 2025-04-22 AU AU2025202786A patent/AU2025202786A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210260225A1 (en) | 2021-08-26 |
| CA3096717A1 (en) | 2019-11-21 |
| SG11202009795PA (en) | 2020-12-30 |
| KR20250030028A (ko) | 2025-03-05 |
| KR20210013553A (ko) | 2021-02-04 |
| JP2024073470A (ja) | 2024-05-29 |
| KR102774917B1 (ko) | 2025-03-04 |
| EP3793621A1 (en) | 2021-03-24 |
| BR112020021358A2 (pt) | 2021-01-19 |
| WO2019222638A1 (en) | 2019-11-21 |
| AU2019269671A1 (en) | 2020-10-22 |
| JP7487184B2 (ja) | 2024-05-20 |
| AU2019269671B2 (en) | 2025-01-30 |
| CN112135641A (zh) | 2020-12-25 |
| JP2021524362A (ja) | 2021-09-13 |
| AU2025202786A1 (en) | 2025-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2022000250A1 (es) | Molécula de unión al antígeno multiespecífica que tiene actividad de sustitución de la función de cofactor del factor viii de coagulación de sangre (fviii) y formulación farmacéutica que contiene tal molécula como ingrediente activo (divisional de la solicitud n°202000767) | |
| UY37952A (es) | Formulaciones de un inhibidor de la quinasa trk macrocíclica | |
| AR107014A1 (es) | Formulación farmacéutica acuosa | |
| BR112021019520A2 (pt) | Composição farmacêutica, método para tratar a síndrome de hunter e uso de uma composição farmacêutica | |
| CY1117941T1 (el) | Υψηλης συγκεντρωσης φapμαkeytika σκευασματα που περιλαμβανουν το αντισωμα κatα cd20 | |
| JP2017222654A5 (enExample) | ||
| UY37997A (es) | Agentes antivirales contra la hepatitis b | |
| JOP20200140B1 (ar) | صيغ لتركيبات لقاح فيروس حُمى الضنك | |
| PE20220017A1 (es) | Inhibidores del kcnt1 y metodos de uso | |
| MX2024001620A (es) | Composiciones estabilizadas de radionucleidos y sus usos. | |
| ES3063402T3 (en) | Stable, concentrated radionuclide complex solutions | |
| CL2019001049A1 (es) | Vacuna contra parvovirus porcino. | |
| AR092470A1 (es) | Formulaciones acuosas estables de adalimumab | |
| AR105712A1 (es) | Composiciones de insulina de rápida acción | |
| UY36542A (es) | Formulaciones farmacéuticas para anticuerpos anti-tnf-alfa | |
| MX2019002781A (es) | Estabilizadores de mastocitos para el tratamiento de hipercitoquinemia e infeccion viral. | |
| MX2021004331A (es) | Composiciones estables de semaglutida y usos de las mismas. | |
| EA200970274A1 (ru) | Способы введения гипогликемических средств с длительным действием | |
| MX2021011635A (es) | Compuesto para el secuestro de anticuerpos no deseables en un paciente. | |
| CL2022001035A1 (es) | Composiciones y métodos para minimizar la pérdida de proteínas a concentraciones de proteínas bajas | |
| MX2019000235A (es) | Eliminacion de la cistina mediada por enzimas humanas. | |
| MX2016012447A (es) | Formulaciones de factor ix liofilizadas. | |
| MX2019013458A (es) | Disminucion de homocisteina mediada por enzimas humanas para el tratamiento de pacientes con hiperhomocisteinemia y homocistinuria. | |
| CL2020002561A1 (es) | Composiciones y métodos para el tratamiento de la distrofia macular | |
| AR092691A1 (es) | Composicion farmaceutica que comprende rebamipida |